Insights and examples of how collaborative efforts can lead to the development of innovative therapies that target unmet patient needs.
Bertrand Ducrey
Advertisement
Bertrand Ducrey, Ph.D., is the CEO of Debiopharm, a Swiss-based global biopharmaceutical company.
Articles by Bertrand Ducrey
Advertisement
Latest Updated Articles
The Importance of Collaborative Business Models for Drug DevelopmentPublished: April 27th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
2
Join Us Tonight: Inside Trump’s Drug Price Plan
3
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
4
Roundup: Biotech’s Most Recent Strategic Partnerships and Exclusive Licensing Agreements
5
